Clinical Trials Browser

Phase 2 × Hematologic Neoplasms × posaconazole × Clear all

NCT06541067 2026-01-26

POSALLO

Phase 2 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms

NCT04294641 2026-01-23

Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease

Phase 2 Completed

10 enrolled 15 charts

Other hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Hematologic Neoplasms